(Q79083635)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Infliximab in the treatment of medically refractory indeterminate colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

K A Papadakis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

L Treyzon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

P R Fleshner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

E A Vasiliauskas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

19 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

741-747

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

Infliximab in Crohn's disease: first anniversary clinical experience

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01739.X

Clinical experience with infliximab therapy in 100 patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01739.X

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01739.X

Clinical use of Infliximab in Crohn's disease: the Edinburgh experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01739.X

Infliximab for refractory ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01739.X

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01739.X

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01739.X

The immunology of mucosal models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01739.X

INFLIXIMAB DOWNREGULATES INTERFERON-γ PRODUCTION IN ACTIVATED GUT T-LYMPHOCYTES FROM PATIENTS WITH CROHN'S DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01739.X

10.1046/J.1365-2036.2003.01739.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14510748%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference